triple-negative
-
October 4, 2017
New Trends in Pre-Surgery Treatments for Breast Cancer
Emma Shtivelman, PhDNon-metastatic breast cancers are most often treated with surgery, but if the tumors are fairly large, or involve nearby lymph nodes, neoadjuvant (pre-operative) treatments with chemotherapy (NAC) are done first. NAC often reduces the tumor size and kills cancer cells in lymph nodes, if present, prior to surgery, improving the outcome. The best possible result of neoadjuvant treatment is pCR (pathologic compete response), when… Read more »
-
July 12, 2016
New Research on Triple Negative Breast Cancer Emerges at ASCO 2016
Emma Shtivelman, PhDThe American Society of Clinical Oncology (ASCO) meeting of 2016 is behind us, but oncologists, patients, and journalists are still analyzing the most interesting presentations made there. Below, we describe some of the more prominent results in triple negative breast cancer (TNBC), both promising and disappointing.
-
February 8, 2016
Putting Immune Checkpoint Blockade to the Test in Breast Cancer
Emma Shtivelman, PhDAbout 10 months ago, we asked: is there a future for immunotherapy in breast cancer? Now, we can answer this question with a qualified “yes.” The data show why.